Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects

J Allergy Clin Immunol. 1995 Oct;96(4):480-5. doi: 10.1016/s0091-6749(95)70290-3.

Abstract

Objective: Cross-sensitivity between aspirin and acetaminophen in aspirin-sensitive asthmatic patients has been reported with frequencies ranging from 0% to 29%. The relationship is dose-dependent for acetaminophen challenges, ranging between 300 and 100 mg.

Methods: To determine the prevalence of cross-sensitivity to high-dose acetaminophen, we performed single-blind acetaminophen oral challenges with 1000 mg and 1500 mg in 50 aspirin-sensitive asthmatic patients and in 20 non-aspirin-sensitive asthmatic control subjects.

Results: Overall, 17 of 50 (34%) of aspirin-sensitive asthmatic patients reacted to acetaminophen in doses of 1000 to 1500 mg (95% confidence interval: 20% to 49%). By contrast, none of the 20 non-aspirin-sensitive asthmatic patients reacted to acetaminophen (95% confidence interval: 0% to 14%). This difference was highly significant (p = 0.0013), supporting the hypothesis that cross-sensitivity between aspirin and acetaminophen is unique in aspirin-sensitive asthmatic patients.

Conclusion: Although high-dose ( > 1000 mg) acetaminophen cross-reactions with aspirin were significant with respect to frequency (34%), such reactions included easily reversed bronchospasm in only 22%, and were generally mild. We recommended that high doses of acetaminophen (1000 mg or greater) should be avoided in aspirin-sensitive asthmatic patients.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetaminophen / immunology*
  • Acetaminophen / pharmacology
  • Adult
  • Aged
  • Aspirin / immunology*
  • Aspirin / pharmacology
  • Asthma / complications
  • Asthma / immunology*
  • Cross Reactions
  • Dose-Response Relationship, Immunologic
  • Drug Hypersensitivity / complications
  • Drug Hypersensitivity / epidemiology
  • Drug Hypersensitivity / immunology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • Prospective Studies
  • Single-Blind Method

Substances

  • Acetaminophen
  • Aspirin